HUT60136A - Process for producing amino glycoside compositions with reduced nephrotoxicity - Google Patents

Process for producing amino glycoside compositions with reduced nephrotoxicity

Info

Publication number
HUT60136A
HUT60136A HU913392A HU339291A HUT60136A HU T60136 A HUT60136 A HU T60136A HU 913392 A HU913392 A HU 913392A HU 339291 A HU339291 A HU 339291A HU T60136 A HUT60136 A HU T60136A
Authority
HU
Hungary
Prior art keywords
group
carbon atoms
chain
chem
stands
Prior art date
Application number
HU913392A
Other languages
English (en)
Other versions
HU913392D0 (en
HU213509B (en
Inventor
William J Novick
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of HU913392D0 publication Critical patent/HU913392D0/hu
Publication of HUT60136A publication Critical patent/HUT60136A/hu
Publication of HU213509B publication Critical patent/HU213509B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
HU913392A 1990-10-30 1991-10-29 Process for preparing xantine derivative containing pharmaceutical preparation, having nephrotoxicic reducing activity HU213509B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/606,018 US5039666A (en) 1990-10-30 1990-10-30 Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside

Publications (3)

Publication Number Publication Date
HU913392D0 HU913392D0 (en) 1992-01-28
HUT60136A true HUT60136A (en) 1992-08-28
HU213509B HU213509B (en) 1997-07-28

Family

ID=24426160

Family Applications (1)

Application Number Title Priority Date Filing Date
HU913392A HU213509B (en) 1990-10-30 1991-10-29 Process for preparing xantine derivative containing pharmaceutical preparation, having nephrotoxicic reducing activity

Country Status (16)

Country Link
US (1) US5039666A (hu)
EP (1) EP0483634B1 (hu)
JP (1) JP3003333B2 (hu)
KR (1) KR0139199B1 (hu)
AT (1) ATE133072T1 (hu)
AU (1) AU640056B2 (hu)
CA (1) CA2054471C (hu)
DE (1) DE69116503T2 (hu)
DK (1) DK0483634T3 (hu)
ES (1) ES2083500T3 (hu)
GR (1) GR3018824T3 (hu)
HU (1) HU213509B (hu)
IE (1) IE70670B1 (hu)
IL (1) IL99874A (hu)
PT (1) PT99358B (hu)
ZA (1) ZA918592B (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2753395B2 (ja) * 1992-03-04 1998-05-20 セル・セラピューティックス・インコーポレーテッド 鏡像異性体ヒドロキシル化キサンチン化合物
JP3076672B2 (ja) * 1992-06-18 2000-08-14 三井化学株式会社 キノリン誘導体のフマル酸塩
US5288721A (en) * 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
US5340813A (en) * 1992-11-09 1994-08-23 Cell Therapeutics, Inc. Substituted aminoalkyl xanthine compounds
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US6469017B1 (en) * 1998-01-16 2002-10-22 Cell Therapeutics, Inc. Method of inhibiting interleukin-12 signaling
US5473070A (en) * 1992-11-16 1995-12-05 Cell Therapeutics, Inc. Substituted long chain alcohol xanthine compounds
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US5866576A (en) * 1992-12-16 1999-02-02 Cell Therapeutics, Inc. Epoxide-containing compounds
WO1994015605A1 (en) * 1993-01-14 1994-07-21 Cell Therapeutics, Inc. Acetal or ketal substituted therapeutic compounds
WO1994016704A1 (en) * 1993-01-19 1994-08-04 Cell Therapeutics, Inc. Oxime-substituted therapeutic compounds
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
US5641783A (en) * 1993-11-12 1997-06-24 Cell Therapeutics, Inc. Substituted amino alcohol compounds
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
WO1995019171A1 (en) * 1994-01-14 1995-07-20 Cell Therapeutics, Inc. Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf
US6878715B1 (en) * 1994-02-18 2005-04-12 Cell Therapeutics, Inc. Therapeutic compounds for inhibiting interleukin-12 signals and method for using same
EP0746557A4 (en) * 1994-02-18 1997-05-02 Cell Therapeutics Inc INTRACELLULAR SIGNALING MEDIATORS
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US6075029A (en) * 1998-01-02 2000-06-13 Cell Therapeutics, Inc. Xanthine modulators of metabolism of cellular P-450
DE19823396A1 (de) * 1998-05-26 1999-12-02 Bayer Ag Synergistische insektizide Mischungen
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US6586429B2 (en) * 2000-11-29 2003-07-01 Cell Therapeutics, Inc. Tricyclic fused xanthine compounds and their uses
US6825180B2 (en) * 2001-05-18 2004-11-30 Cell Therapeutics, Inc. Pyridopyrimidine compounds and their uses
US7345018B2 (en) 2002-04-25 2008-03-18 Reception Aps Method of treating side effects induced by therapeutic agents
ZA200508482B (en) * 2003-03-26 2007-03-28 Recepticon Aps Use of compounds for the prevention of drug-induced cell toxicity
JP2008515821A (ja) * 2004-10-06 2008-05-15 レセプトイコン・アンパルトセルスカブ 薬物誘発性細胞毒性の予防のための化合物の使用
US7439343B2 (en) * 2005-09-01 2008-10-21 Rensselaer Polytechnic Institute Aminoglycoside-polyamine displacers and methods of use in displacement chromatography
WO2009152202A2 (en) * 2008-06-11 2009-12-17 Utah State University New aminoglycosides: synthesis and use as antifungals
US9669044B2 (en) 2010-12-14 2017-06-06 Utah State University Aminoglycoside and azole compositions and methods
WO2012082650A2 (en) 2010-12-14 2012-06-21 Utah State University Aminoglycosides:synthesis and use as antifungals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029882A (en) * 1974-03-19 1977-06-14 Schering Corporation Selective acylation of the C-1 amino group of aminoglycoside antibiotics
US4002742A (en) * 1974-03-19 1977-01-11 Schering Corporation 1-N-alkyl-4,6-di-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, methods for their use as antibacterial agents, and compositions useful therefor
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0414175A3 (en) * 1989-08-22 1992-04-01 Hoechst Aktiengesellschaft Use of xanthine derivatives to reduce nephrotoxicity

Also Published As

Publication number Publication date
DE69116503D1 (de) 1996-02-29
PT99358B (pt) 1999-03-31
HU913392D0 (en) 1992-01-28
HU213509B (en) 1997-07-28
JP3003333B2 (ja) 2000-01-24
IL99874A0 (en) 1992-08-18
ES2083500T3 (es) 1996-04-16
KR0139199B1 (ko) 1998-05-15
DE69116503T2 (de) 1996-06-20
CA2054471C (en) 1998-09-22
EP0483634B1 (en) 1996-01-17
IE70670B1 (en) 1996-12-11
EP0483634A3 (en) 1992-10-14
IE913775A1 (en) 1992-05-22
AU640056B2 (en) 1993-08-12
GR3018824T3 (en) 1996-04-30
CA2054471A1 (en) 1992-05-01
AU8680291A (en) 1992-05-07
US5039666A (en) 1991-08-13
EP0483634A2 (en) 1992-05-06
KR920007630A (ko) 1992-05-27
IL99874A (en) 1995-08-31
DK0483634T3 (da) 1996-05-20
ZA918592B (en) 1992-07-29
ATE133072T1 (de) 1996-02-15
PT99358A (pt) 1992-09-30
JPH04282315A (ja) 1992-10-07

Similar Documents

Publication Publication Date Title
HUT60136A (en) Process for producing amino glycoside compositions with reduced nephrotoxicity
EP0694558A4 (en) SPHINGOGLYCOLIPID AND USE THEREOF
FR2696458B1 (fr) Procédé de préparation de dérivés du taxane.
IE890359L (en) Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AU660469B2 (en) Pharmacologically active hydrazine derivatives and processes for the preparation thereof
CA2085345A1 (en) Pyrimidine nucleoside derivatives
ES8200679A1 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
HUT61773A (en) Process for producing spicamycin derivatives and pharmaceutical compositions containing them as active components
KR920009398A (ko) 사람의 이인자형 이식반응 영향을 억제하는데 효과적인 약제를 제조하기 위한 크산틴의 용도
BR9604907B1 (pt) derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral com princìpios ativos.
IL105901A0 (en) Novel estradiol derivative-chlorambucil conjugate,process for preparing the same,and pharmaceutical compositions
MA20829A1 (fr) Nouvelles anthracyclines et compositions les contenant
ES467861A1 (es) Procedimiento de preparacion de espiro-oxazolidinas esteroi-des y sus esteroisomeros.
ES8105319A1 (es) Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas
ES8104182A1 (es) Procedimiento para preparar diaminas alquiladas
DE3275083D1 (en) Cycloaliphatic alcohols
BG60269B2 (en) Process for the preparation of pyrimidine trione derivatives
YU128191A (sh) Postupak za dobijanje 6-acilnih, 7-acilnih i 6,7-diacilnih analoga forskolina i njegovih intermedijata
MX9708785A (es) El uso de poliglucosidos de alquilo c16-c18, como desespumantes en composiciones de limpieza.

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: HOECHST MARION ROUSSEL, INCORPORATED, US

HMM4 Cancellation of final prot. due to non-payment of fee